New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 4, 2013
16:48 EDTHUMHumana expects higher sales for individual Medicare Advantage plans in 2013
Humana will be meeting with investors and analysts at an industry conference on January 8, 2013. During the meetings, the company intends to address its prospects and performance. The company expects gross sales for individual Medicare Advantage plans for 2013 to be slightly higher than previously expected. Data from the Centers for Medicare and Medicaid Services indicates attrition in the company’s individual Medicare Advantage plans is also slightly higher than the company’s previous expectations. The company continues to expect net growth for individual Medicare Advantage membership of 100,000 to 120,000, net of the January 1, 2013 disposition of approximately 12,600 Medicare Advantage members acquired in the March 31, 2012 acquisition of Arcadian Management Services. Gross sales for the company’s stand-alone Prescription Drug Plans for 2013 are anticipated to be slightly below the range of previous expectations. Prescription Drug Plans disenrollment data indicates attrition is also slightly below the company’s previous expectations. The company continues to anticipate net membership growth for 2013 in its stand-alone Prescription Drug Plans in the range of 125,000 to 175,000.
News For HUM From The Last 14 Days
Check below for free stories on HUM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2014
12:01 EDTHUMHumana, Dignity Health sign agreement
Subscribe for More Information
10:08 EDTHUMUnitedHealth retreats after Citi cuts rating on shares
Subscribe for More Information
April 15, 2014
06:32 EDTHUMPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
April 8, 2014
11:02 EDTHUMHumana now sees 2015 CMS Medicare Advantage funding decline of 3%
Subscribe for More Information
10:18 EDTHUMCMS says Medicare Advantage reimbursement to rise in 2015
Subscribe for More Information
09:23 EDTHUMLeerink views final rates as favorable for MA plans
Subscribe for More Information
April 7, 2014
19:13 EDTHUMCMS issues 2015 rate announcement for Medicare Advantage and Part D programs
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use